John Maraganore - 06 Jun 2024 Form 3 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Reporting relationship: Director
Issuer ticker: RAPP
Reported as of: 06 Jun 2024
Net transaction value: $0
SEC form: 3
Accepted by SEC: 06 Jun 2024, 18:56:44 UTC
Prior SEC filing: 07 Jun 2024
Next SEC filing: 20 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Cheryl Gault, Attorney-in-Fact

Key filing fact

John Maraganore filed Form 3 for Rapport Therapeutics, Inc. (RAPP) on 06 Jun 2024.

Key facts

This page summarizes John Maraganore's Form 3 filing for Rapport Therapeutics, Inc. (RAPP).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Jun 2024, 18:56.

Change

Previous filing in this sequence was filed on 07 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RAPP holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 06 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 87,567
Exercise price: $9.60
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option vest and become exercisable in sixteen (16) equal quarterly installments, with the first installment vesting on April 18, 2024, subject to the Reporting Person's continued service on each such vesting date.

SEC remarks

Exhibit 24 - Power of Attorney